Acquisitions (Tables)

12 Months Ended

Dec. 31, 2018

Business Combinations [Abstract]

Schedule of Assets Acquired and Liabilites Assumed

The following table shows the allocation of the purchase price of Jamestown Regional Medical Center to the acquired identifiable assets acquired, and liabilities assumed:

Total purchase price	$	635,096
Tangible and intangible assets acquired, and liabilities assumed at estimated fair value:
Cash	$	375
Inventories		450,682
Prepaids and deposits		310,385
Property and equipment		7,129,484
Intangible assets		504,806
Accrued expenses		(193,966	)
Net tangible and intangible assets acquired	$	8,201,766
Gain on bargain purchase	$	7,566,670

Schedule of Intangible Assets Acquisition

The intangible assets acquired in the Jamestown acquisition consisted of the following at December 31, 2018:

	Acquired in 2018		Life	Impairment in 2018			Amortization for the Year Ended December 31, 2018			Carrying Value December 31, 2018
Certificate of need	$	259,443	Infinite	$	-		$	-		$	259,443
Non-compete		245,363	2 yrs.		(173,799	)		(71,564	)		-
Total intangibles	$	504,806		$	(173,799	)	$	(71,564	)	$	259,443

Schedule of Impaired Asset of Operations Results

As noted in the table above, we fully impaired the non-compete intangible asset acquired in the acquisition of Jamestown Regional Medical Center at December 31, 2018. We determined that this asset was impaired primarily due to the operating results of Jamestown Regional Medical Center since the acquisition on June 1, 2018, which were as follows:

	For the Period June 1, 2018 to December 31, 2018 (unaudited)
Net Revenue	$	7,898,222
Net Loss	$	(2,022,380

Schedule of Unaudited Pro-forma of Results of Operations

The following presents the unaudited pro-forma combined results of operations of the Company and Jamestown Regional Medical Center as if the acquisition had occurred on January 1, 2017.

	Year Ended
	December 31,
	2018			2017
	(unaudited)
Net revenue	$	19,983,266		$	19,446,732
Net loss from continuing operations		(15,720,672	)		(55,305,325	)
Net loss		(16,155,515	)		(59,582,243	)
Deemed dividend from trigger of down round provision feature		(231,843,826	)		(53,341,619	)
Net loss to common stockholders	$	(247,999,341	)	$	(112,923,862	)
Net loss per common share:
Basic and diluted continuing operations	$	(24.70	)	$	(23,537.03	)
Basic and diluted net loss to common stockholders	$	(24.75	)	$	(24,463.57	)